Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Therapeutic problems of a pregnant patient with juvenile glaucoma faced after photorefractive keratectomy

Poster Details

First Author: A.Sallai HUNGARY

Co Author(s):    A. Popper-Sachetti   Z. Pelle           

Abstract Details



Purpose:

Our purpose was to try to find the best anti-glaucoma treatment for our pregnant patient with juvenile glaucoma and in the meantime to lower as much as we can the teratogen fetal risk and to preserve the mothers vision and visual field.

Setting:

Pándy Kálmán County Hospitals' Ophthalmology Department,Hungary

Methods:

Juvenile glaucoma was diagnosed only one year after photorefractiv keratectomy was made. Trabeculectomy was performed on both of our patient's eyes before her two pregnancies. Based on our common agreement with the mother-to-be, we did not use medical anti-glaucoma therapy. We have been treating our patient with juvenile glaucoma for 15 years. In this time she gave birth to two healthy children. From an ophthalmic point of view, it was a big challenge to treat the mother's glaucoma during the pregnancy, because of the lack of available case studies in this theme.

Results:

Trabeculectomy on both of our patient's eye ensured a good IOP without the use of antiglaucomatous treatment.

Conclusions:

Trabeculectomy stopped the progression of visual field and visual acuity worsening during the two pregnancies, despite the advanced stage of juvenile glaucoma of our patient. The fetal teratogen risk was also avoided by skipping the medical anti glaucoma treatment. FINANCIAL INTEREST: NONE

Back to Poster listing